Related Post
On Monday, Cameroon launched the world's first regular vaccination program against the disease Malaria This represents a boost to the global war on mosquito-borne disease, and the program is expected to save the lives of tens of thousands of children annually across Africa.
The vaccine, which took about 40 years to develop and is manufactured by GlaxoSmithKline and approved by the World Health Organization, is supposed to work in conjunction with currently available tools, such as mosquito nets, to combat malaria, which kills nearly half a million children without children. Age five in Africa every year.
According to the Global Vaccine Alliance (GAVI), Cameroon has become the first country to offer the vaccine through a regular vaccination program that 19 other countries aim to launch this year, after successful trials in several countries, including Ghana and Kenya.
Malaria vaccination targets about 6.6 million children in these countries during the years 2024 and 2025.
The need for malaria vaccinations is urgent. The World Health Organization says that the disruptions associated with the “Covid-19” pandemic, the rise in insecticide resistance, and other issues have hampered efforts to combat malaria in the past few years, as infection cases rose by about 5 million cases on an annual basis in 2022.
